189 related articles for article (PubMed ID: 37663753)
1. Understanding the role of conserved proline and serine residues in the SARS-CoV-2 spike cleavage sites in the virus entry, fusion, and infectivity.
Khatri R; Lohiya B; Kaur G; Maithil V; Goswami A; Sarmadhikari D; Asthana S; Samal S
3 Biotech; 2023 Oct; 13(10):323. PubMed ID: 37663753
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
Lavie M; Dubuisson J; Belouzard S
J Virol; 2022 Jul; 96(13):e0047422. PubMed ID: 35678602
[TBL] [Abstract][Full Text] [Related]
3. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide bioinformatics analysis of human protease capacity for proteolytic cleavage of the SARS-CoV-2 spike glycoprotein.
Matveev EV; Ponomarev GV; Kazanov MD
Microbiol Spectr; 2024 Feb; 12(2):e0353023. PubMed ID: 38189333
[TBL] [Abstract][Full Text] [Related]
5. A substrate for a cell free in vitro assay system to screen drugs targeting trypsin like protease-based cleavage of SARS-CoV-2 spike glycoprotein and viral entry.
Begum F; Srivastava AK; Tripathi PP; Ray U
J Med Virol; 2023 May; 95(5):e28796. PubMed ID: 37218551
[TBL] [Abstract][Full Text] [Related]
6. Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease.
Stevaert A; Van Berwaer R; Mestdagh C; Vandeput J; Vanstreels E; Raeymaekers V; Laporte M; Naesens L
mBio; 2022 Aug; 13(4):e0137622. PubMed ID: 35913162
[TBL] [Abstract][Full Text] [Related]
7. Roles of host proteases in the entry of SARS-CoV-2.
Zabiegala A; Kim Y; Chang KO
Anim Dis; 2023; 3(1):12. PubMed ID: 37128508
[TBL] [Abstract][Full Text] [Related]
8. The "LLQY" Motif on SARS-CoV-2 Spike Protein Affects S Incorporation into Virus Particles.
Du S; Xu W; Wang Y; Li L; Hao P; Tian M; Wang M; Li T; Wu S; Liu Q; Bai J; Qu X; Jin N; Zhou B; Liao M; Li C
J Virol; 2022 Mar; 96(6):e0189721. PubMed ID: 35045269
[TBL] [Abstract][Full Text] [Related]
9. Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein.
Yamamoto M; Gohda J; Kobayashi A; Tomita K; Hirayama Y; Koshikawa N; Seiki M; Semba K; Akiyama T; Kawaguchi Y; Inoue JI
mBio; 2022 Aug; 13(4):e0051922. PubMed ID: 35708281
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic activation of SARS-CoV-2 spike protein.
Takeda M
Microbiol Immunol; 2022 Jan; 66(1):15-23. PubMed ID: 34561887
[TBL] [Abstract][Full Text] [Related]
11. Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects.
Nguyen HT; Zhang S; Wang Q; Anang S; Wang J; Ding H; Kappes JC; Sodroski J
J Virol; 2021 Mar; 95(5):. PubMed ID: 33310888
[TBL] [Abstract][Full Text] [Related]
12. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites.
Belouzard S; Chu VC; Whittaker GR
Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5871-6. PubMed ID: 19321428
[TBL] [Abstract][Full Text] [Related]
13. Herbal Compounds Dauricine and Isoliensinine Impede SARS-CoV-2 Viral Entry.
Dabrell SN; Li YC; Yamaguchi H; Chen HF; Hung MC
Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001915
[TBL] [Abstract][Full Text] [Related]
14. In silico analysis of mutations near S1/S2 cleavage site in SARS-CoV-2 spike protein reveals increased propensity of glycosylation in Omicron strain.
Beaudoin CA; Pandurangan AP; Kim SY; Hamaia SW; Huang CL; Blundell TL; Vedithi SC; Jackson AP
J Med Virol; 2022 Sep; 94(9):4181-4192. PubMed ID: 35575289
[TBL] [Abstract][Full Text] [Related]
15. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells.
Hoffmann M; Kleine-Weber H; Pöhlmann S
Mol Cell; 2020 May; 78(4):779-784.e5. PubMed ID: 32362314
[TBL] [Abstract][Full Text] [Related]
16. Epitope-directed anti-SARS-CoV-2 scFv engineered against the key spike protein region could block membrane fusion.
Jaiswal D; Kumar U; Gaur V; Salunke DM
Protein Sci; 2023 Mar; 32(3):e4575. PubMed ID: 36691733
[TBL] [Abstract][Full Text] [Related]
17. The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2.
Winstone H; Lista MJ; Reid AC; Bouton C; Pickering S; Galao RP; Kerridge C; Doores KJ; Swanson CM; Neil SJD
J Virol; 2021 Apr; 95(9):. PubMed ID: 33563656
[TBL] [Abstract][Full Text] [Related]
18. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets.
Peacock TP; Goldhill DH; Zhou J; Baillon L; Frise R; Swann OC; Kugathasan R; Penn R; Brown JC; Sanchez-David RY; Braga L; Williamson MK; Hassard JA; Staller E; Hanley B; Osborn M; Giacca M; Davidson AD; Matthews DA; Barclay WS
Nat Microbiol; 2021 Jul; 6(7):899-909. PubMed ID: 33907312
[TBL] [Abstract][Full Text] [Related]
19. Reactive Centre Loop Mutagenesis of SerpinB3 to Target TMPRSS2 and Furin: Inhibition of SARS-CoV-2 Cell Entry and Replication.
Singh S; O'Reilly S; Gewaid H; Bowie AG; Gautier V; Worrall DM
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293378
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein.
Kleine-Weber H; Elzayat MT; Hoffmann M; Pöhlmann S
Sci Rep; 2018 Nov; 8(1):16597. PubMed ID: 30413791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
